Mach7 Technologies Ltd
ASX:M7T

Watchlist Manager
Mach7 Technologies Ltd Logo
Mach7 Technologies Ltd
ASX:M7T
Watchlist
Price: 0.36 AUD 2.86% Market Closed
Market Cap: 86.8m AUD
Have any thoughts about
Mach7 Technologies Ltd?
Write Note

Mach7 Technologies Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Mach7 Technologies Ltd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Mach7 Technologies Ltd
ASX:M7T
Cash & Cash Equivalents
AU$26.2m
CAGR 3-Years
13%
CAGR 5-Years
63%
CAGR 10-Years
47%
4DMedical Ltd
ASX:4DX
Cash & Cash Equivalents
AU$30.6m
CAGR 3-Years
-28%
CAGR 5-Years
58%
CAGR 10-Years
N/A
CogState Ltd
ASX:CGS
Cash & Cash Equivalents
$30.1m
CAGR 3-Years
8%
CAGR 5-Years
56%
CAGR 10-Years
41%
Pro Medicus Ltd
ASX:PME
Cash & Cash Equivalents
AU$60.1m
CAGR 3-Years
13%
CAGR 5-Years
20%
CAGR 10-Years
16%
Medibio Ltd
ASX:MEB
Cash & Cash Equivalents
AU$214.1k
CAGR 3-Years
-36%
CAGR 5-Years
-49%
CAGR 10-Years
N/A
Medadvisor Ltd
ASX:MDR
Cash & Cash Equivalents
AU$15.6m
CAGR 3-Years
30%
CAGR 5-Years
29%
CAGR 10-Years
45%
No Stocks Found

Mach7 Technologies Ltd
Glance View

Market Cap
86.8m AUD
Industry
Health Care

Mach7 Technologies Ltd. provides medical imaging software and services for healthcare institutions. The company is headquartered in Melbourne, Victoria and currently employs 90 full-time employees. The company went IPO on 2005-11-30. The principal activities of the Company include the provision of enterprise imaging data sharing, storage and interoperability for healthcare enterprises globally. The firm operates through two segments: sale of software and rendering of professional services. The sale of software segment engaged in selling software licenses. The provision of the software license is a distinct performance obligation as the customer can derive substantial benefits from the license on its own when the license is delivered and installed. Healthcare enterprises globally segment engaged in providing professional services, such as implementation, training and annual support services. The firm provides various solutions, including Enterprise Diagnostic Viewing, Enterprise Data Management and Enterprise PACS.

M7T Intrinsic Value
0.55 AUD
Undervaluation 35%
Intrinsic Value
Price

See Also

What is Mach7 Technologies Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
26.2m AUD

Based on the financial report for Jun 30, 2024, Mach7 Technologies Ltd's Cash & Cash Equivalents amounts to 26.2m AUD.

What is Mach7 Technologies Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
47%

Over the last year, the Cash & Cash Equivalents growth was 12%. The average annual Cash & Cash Equivalents growth rates for Mach7 Technologies Ltd have been 13% over the past three years , 63% over the past five years , and 47% over the past ten years .

Back to Top